Hypoxia-Induced and Glucuronic Acid-Modified Extracellular Vesicles from Mesenchymal Stromal Cells Treat Pulmonary Arterial Hypertension by Improving Vascular Remodeling
Nano Letters · 25.12.2024 · 24 (51) · 16342-16350
DOI: 10.1021/acs.nanolett.4c04638 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nano Letters, online erschienen am 11.12.2024. Verfasst von Qingfu Zhu und 8 weiteren Autor:innen. Beteiligte Einrichtung: National Engineering Research Center of Ophthalmology and Optometry, School of Biomedical Engineering, Eye Hospital, Wenzhou Medical University,Xueyu…. Hauptthemen laut MEDLINE: Mesenchymal Stem Cells, Extracellular Vesicles, Vascular Remodeling, Pulmonary Arterial Hypertension. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Achieving precise delivery of extracellular vesicles (EVs) to treat pulmonary arterial hypertension (PAH) remains challenging. Here, we propose a strategy using hypoxia-induced and glucuronic acid (GA)-modified mesenchymal stromal-cell-derived EVs (MSC-EVs) to enhance their functionalities and therapeutic targeting. The hypoxia-induced EVs (Hypo-EVs) exhibit enriched exosomal signatures and display heightened inhibition of the proliferation of pulmonary arterial smooth muscle cells (PASMCs) compared to normoxic EVs (Norm-EV). We then modify Hypo-EVs by incorporating GA into their outer membrane, targeting glucose transporter-1 overexpressed on PASMCs. Our studies show that GA-EVs significantly enhance the therapeutic efficacy, both in vitro and in vivo, through improved targeted delivery to diseased PASMCs for improving vascular remodeling. Additionally, we identify miR-5119 involved in the PAH-associated calcium signaling pathway as a key contributor to GA-EVs' superior effects. This work provides a promising strategy for PAH treatment and advances the clinical potential of MSC-EV-based therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- National Engineering Research Center of Ophthalmology and Optometry, School of Biomedical Engineering, Eye Hospital, Wenzhou Medical University,Xueyuan Road 270, Wenzhou 325027, China.
- Division of Pulmonary Medicine, The First Affiliated Hospital, Wenzhou Medical University, Wenzhou, Zhejiang 325000, China.
- Wenzhou Key Laboratory of Interdiscipline and Translational Medicine, Wenzhou Key Laboratory of Heart and Lung, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang 325000, China.
ORCID-Profile: Qingfu Zhu
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Zhu, Q., Mao, X., Zhu, X., Xiao, Y., Xu, H., Su, L., Liu, X., Huang, X., & Wang, L. (2024). Hypoxia-Induced and Glucuronic Acid-Modified Extracellular Vesicles from Mesenchymal Stromal Cells Treat Pulmonary Arterial Hypertension by Improving Vascular Remodeling. Nano Letters, 24(51), 16342-16350. https://doi.org/10.1021/acs.nanolett.4c04638
Vancouver
Zhu Q, Mao X, Zhu X, Xiao Y, Xu H, Su L, et al. Hypoxia-Induced and Glucuronic Acid-Modified Extracellular Vesicles from Mesenchymal Stromal Cells Treat Pulmonary Arterial Hypertension by Improving Vascular Remodeling. Nano Letters. 2024;24(51):16342-16350. doi:10.1021/acs.nanolett.4c04638
BibTeX
@article{Zhu2024,
author = {Zhu, Qingfu and Mao, Xulong and Zhu, Xinxi and Xiao, Yijia and Xu, Hao and Su, Lihuang and Liu, Xiaohu and Huang, Xiaoying and Wang, Liangxing},
title = {Hypoxia-Induced and Glucuronic Acid-Modified Extracellular Vesicles from Mesenchymal Stromal Cells Treat Pulmonary Arterial Hypertension by Improving Vascular Remodeling},
journal = {Nano Letters},
year = {2024},
volume = {24},
number = {51},
pages = {16342--16350},
doi = {10.1021/acs.nanolett.4c04638}
}
EUVIMED